Patrick Flavin
Corporate Officer/Principal at Autobahn Therapeutics, Inc.
Profile
Patrick Flavin is currently the Director-Corporate Development & Strategy at Autobahn Therapeutics, Inc. Prior to this, he worked as an Associate at Illinois Ventures LLC from 2017 to 2019, and as the Head-Corporate Development at Aptinyx, Inc. from 2019 to 2023.
Mr. Flavin holds an MBA from Gies College of Business, which he obtained in 2017.
Patrick Flavin active positions
Companies | Position | Start |
---|---|---|
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 2023-09-30 |
Former positions of Patrick Flavin
Companies | Position | End |
---|---|---|
APTINYX | Corporate Officer/Principal | 2023-08-31 |
Illinois Ventures LLC
Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Corporate Officer/Principal | 2019-08-31 |
Training of Patrick Flavin
Gies College of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
APTINYX | Health Technology |
Private companies | 2 |
---|---|
Illinois Ventures LLC
Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Finance |
Autobahn Therapeutics, Inc.
Autobahn Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Autobahn Therapeutics, Inc. is a thyromimetics drug discovery company. It serves patients with neurodegenerative disorders. The company is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Patrick Flavin